Showing results (101-110 of 344) with videos related to

Sort By:
Pageof 35
Cancer Research and Treatment|November 6, 2025
Real World Efficacy and Safety of First Line Chemo Immunotherapy in Extensive Stage Small Cell Lung Cancer and its association with molecular subtypeMiran Han, Sehhoon Park, Se-Hoon Lee, et al.
Head & Neck|December 30, 2014
Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapyJi Hyun Chang, Yong Chan Ahn, Hyojung Park, et al.
Plos One|May 11, 2018
Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasisSoo Bin Park, Jung Mi Park, Seung Hwan Moon, et al.
Cancers|November 25, 2023
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic AlterationsSoojin Jun, Sehhoon Park, Jong-Mu Sun, et al.
Cancer Research and Treatment|May 6, 2021
Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive TreatmentHongsik Kim, Sehhoon Park, Hyun Ae Jung, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2012
ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosisHee Kyung Ahn, Boram Han, Su Jin Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2013
Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancerJong-Mu Sun, Sanjay Rampal, Genehee Lee, et al.
Hippocampus|June 5, 2013
Iron deficiency with or without anemia impairs prepulse inhibition of the startle reflexMarc T Pisansky, Robert J Wickham, Jianjun Su, et al.
Cancer Medicine|February 7, 2020
PD-1 inhibitors for non-small cell lung cancer patients with special issues: Real-world evidenceSeonggyu Byeon, Jang Ho Cho, Hyun Ae Jung, et al.
Investigational New Drugs|January 1, 2022
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell lung cancerBo Mi Ku, Jae Yeong Heo, Jinchul Kim, et al.
Pageof 35